Raising HDL beats further LDL loweringBut controversial add-on drug trial measured plaque buildup, not clinical endpoints Off-pump bypass comes up short New lipid guidelines focus on LDL targets Long-term BP control achieved with renal nerve ablation Experimental procedure has helped patients with refractory hypertension without causing adverse effects on kidney Everolimus-eluting stent goes to head of class Ezetimibe-atorvastatin combo proves effective Pregnancy feasible for heart recipients But better counselling needed on drug risks and long-term maternal survival Antiplatelet agents unaffected by proton pump inhibitors Resynchronization slows heart failure progression But study results leave cardiologists wrestling with questions of cost and patient selection Doubling clopidogrel dose makes for safer angioplasty Decrease in heart attack and thrombosis risk outweighs rise in severe bleeding: Canadian study First Previous 94 95 96 97 98 Next Last
